Chlorpromazine-induced refractile corneal deposits and cataract.
Leung
A T
AT
Cheng
A C
AC
Chan
W M
WM
Lam
D S
DS
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000378:metabolism; D002386:Cataract / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D002746:Chlorpromazine / Q000009:adverse effects* / Q000378:metabolism; D003316:Corneal Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology; D005260:Female; D006801:Humans; D008875:Middle Aged
D014150:Antipsychotic Agents; D002746:Chlorpromazine